impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Pain in other rheumatic diseases

 

Open issues in the assessment and management of pain in juvenile idiopathic arthritis

1, 2, 3, 4, 5, 6

 

  1. Università degli Studi di Genova and Istituto Giannina Gaslini, Genova, Italy.
  2. Università degli Studi di Genova and Istituto Giannina Gaslini, Genova, Italy.
  3. Università degli Studi di Genova and Istituto Giannina Gaslini, Genova, Italy.
  4. Università degli Studi di Genova and Istituto Giannina Gaslini, Genova, Italy.
  5. Università degli Studi di Genova and Istituto Giannina Gaslini, Genova, Italy.
  6. Università degli Studi di Genova and Istituto Giannina Gaslini, Genova, Italy. angeloravelli@gaslini.org

CER10791
2017 Vol.35, N°5 ,Suppl.107
PI 0123, PF 0126
Pain in other rheumatic diseases

Free to view
(click on article PDF icon to read the article)

PMID: 28967364 [PubMed]

Received: 06/09/2017
Accepted : 06/09/2017
In Press: 28/09/2017
Published: 29/09/2017

Abstract

Pain is the major symptom of children with juvenile idiopathic arthritis (JIA) and its reduction is a key goal of treatment. It is widely agreed that assessment of pain is a fundamental component of the rheumatology evaluation and should be carried out at each clinic visit. However, so far there has been insufficient attention to the impact and causes of pain in children with chronic arthritis in both clinical practice and research. Quantitative measures of pain are seldom used regularly in daily care and pain assessment has not been incorporated in the most popular composite outcome measures for JIA, including the criteria employed to measure improvement in therapeutic trials. A recent advance in the development of pain tools involves mobile devices, particularly smartphones, and the internet to collect real-time self-reported data via electronic diaries. Concern has been raised by the recent observations of persistence of pain in some children with JIA despite adequate treatment with the modern biologic medications and good disease controls. These findings underscore the need of large-scale studies of the prevalence and determinants of pain in patients treated with contemporary care. In addition, the reasons that explain the persistence of pain after the resolution of the inflammatory process should be investigated through research on neurobiological mechanisms of pain and by addressing the role of factors external to the disease, such as mood, anxiety, and pain sensitisation and coping.

Rheumatology Article